Compare MAX & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAX | QSI |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 722.8M | 165.3M |
| IPO Year | 2020 | N/A |
| Metric | MAX | QSI |
|---|---|---|
| Price | $9.25 | $0.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $14.58 | $1.00 |
| AVG Volume (30 Days) | 655.0K | ★ 3.0M |
| Earning Date | 04-29-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.81 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $1,113,600,000.00 | N/A |
| Revenue This Year | $12.70 | N/A |
| Revenue Next Year | $9.32 | $618.07 |
| P/E Ratio | $23.26 | ★ N/A |
| Revenue Growth | ★ 28.78 | N/A |
| 52 Week Low | $7.09 | $0.76 |
| 52 Week High | $13.92 | $3.10 |
| Indicator | MAX | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 44.04 | 30.70 |
| Support Level | $7.09 | N/A |
| Resistance Level | $11.10 | $1.11 |
| Average True Range (ATR) | 0.38 | 0.06 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 18.63 | 0.49 |
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.